LONDON & NEW ZEALAND – (June 8, 2021) – Argenta today announced that Peter McCarthy has been appointed Chief Operating Officer North America, a new executive position within Argenta. Effective immediately, Peter will oversee Argenta’s business operations and strategic initiatives in the United States, working closely together with Edward McGruder, Global Head of Research, Development & Innovation, and Stephen Sibson, Global Head of Manufacturing.
“Peter is a seasoned and trusted leader with vast experience, extensive knowhow and a large network in the animal health industry. He is uniquely qualified to drive strategic growth within Argenta, with a laser-focus on operational excellence. I have immense confidence in Peter’s ability to strengthen our company, and with that, contribute to the success of our customers” said Ben Russell, CEO of Argenta.
Prior to joining Argenta, Peter McCarthy was President and CEO of Henry Schein Global Animal Health Group. During his tenure he led tremendous growth, both organically and inorganically, building the Henry Schein Animal Health business to become the largest distribution-based network globally. Before that, Peter had several international leadership roles with Schering-Plough and Intervet/Schering-Plough, now Merck Animal Health (MSD Animal Health outside the USA and Canada). Most recently he was Practice Lead Commercial & Strategy at Stonehaven Consulting.
“Argenta’s compelling strategy and vision to grow and transform to become the leading global end-to-end veterinary pharma services platform will benefit the broader animal health market,” said Peter McCarthy. “I am incredibly energized to connect and work with a group of likeminded people to help lead the company to its next phase of growth. Argenta’s unwavering focus on delivering customer excellence and advancing animal health through innovation will continue to propel us forward.”
Argenta is the only combined global contract research organization (CRO) and contract development and manufacturing organization (CDMO) dedicated to animal health. Founded in 2006 in New Zealand, Argenta’s talented, diverse and committed employees work on a daily basis to deliver excellence in animal health to customers around the world. With research and GMP manufacturing operations in New Zealand, the United States and the United Kingdom, Argenta operates ‘from Molecule to Market’ in partnership with its customers to support their R&D, regulatory, clinical research and manufacturing needs along the veterinary product development journey. For more information about Argenta, please visit www.argentaglobal.com and follow Argenta on LinkedIn.
Annemieke de Keijzer